ライフサイエンスコーパス: (was|were) similar in

1 Incidence of adverse events was similar in all groups (43 [88%] of 49 in the TRF-budesoni

2 The incidence of adverse events was similar in all three groups.

3 CDI incidence was similar in both exposure groups.

4 rs" (42%), while 15 (58%) had a matching mutation; survival was similar in both groups (P = 0.36).

5 Intracranial pressure control was similar in both groups.

6 Adherence was similar in both groups.

7 Our results showed that the overall timecourse of adaption was similar in both HMD-VR and CT.

8 burning, diesel vehicle, gasoline vehicle, and dust sources was similar in chemical composition between cities, but PM2.5

9 in patients with devices (p = 0.25) Neurocognitive function was similar in control subjects and patients with devices, bu

10 The number of infant deaths at age 0-6 months was similar in each group (50 in the placebo group and 61 in

11 Occurrence of extra-intestinal manifestations was similar in elderly and adult patients, but bowel surgery

12 Alcohol relapse was similar in Group 1 versus Group 2: 23.5% versus 29.2% (P

13 te affinity nitrogen assimilation enzymes (GS-GOGAT system) was similar in growth-limiting and non-limiting nitrogen conc

14 ved in lesional vs nonlesional AD, TCR repertoire diversity was similar in lesional and nonlesional tissues, and absolute

15 horts, CKD was associated with an increased risk of HF that was similar in magnitude to CHD and greater than stroke.

16 ajor vascular events (OR, 0.946 [95% CI, 0.921-0.972]) that was similar in magnitude to the association between the HMGCR

17 re than 80% of the leukocyte blood gene expression response was similar in male and female patients.

18 vival was worse in patients with MVO (P=0.014), although it was similar in patients with and without NR (P=0.33).

19 Overall survival improvement was similar in patients with squamous (HR 0.73 [95% CI 0.54-0

20 Transplant outcome was similar in recipients of organs from donors with and with

21 The chromatographic profile of betalains was similar in SpR, SpO, and SsR, where indicaxanthin, gomphr

22 ion of H1 and H2 blockers, corticosteroids, and epinephrine was similar in the 2 treatment groups.

23 The incidence of ALRI hospitalizations was similar in the IIV and placebo group for infants >3 month

24 proportion of children missing two or more scheduled visits was similar in the intervention group and control group (27 [

25 Weight gain was similar in the lower- and higher-protein groups: mean (95

26 The occurrence of anti-drug antibodies was similar in the treatment groups (five [2%] of 268 patient

27 on of positive instances in both loading and leakage models was similar in the two databases screened.

28 Mortality after the start of study treatment was similar in the two study groups: 30 children died in the

29 After adjustment, 1-year mortality was similar in these patients to that in patients who receive

30 s with hemoglobinopathies, change in mean hemoglobin levels was similar in those receiving EBR/GZR compared to those rece

31 But the decomposition of labile SOC was similar in warmed plots compared to the control.

32 The SPK and LDK recipients were similar in age (41.2 +/- 6.9 years vs 40.5 +/- 10.3 year

33 The corneal densitometry values were similar in all concentric zones and layers in both group

34 Discontinuation due to adverse events were similar in both arms (6% lapatinib and 5% placebo).

35 Adverse events were similar in both groups and uncommon.

36 Demographic characteristics and hospital courses were similar in both groups, and birth weights ranged from 58

37 Baseline characteristics were similar in both groups.

38 sitive tissue fractions (MSF), in relation to fresh weight, were similar in both species (E. cyaneus: 0.25 +/- 0.06 mug g

39 Importantly, CD4(+) T cell responses in vaccinees were similar in magnitude and breadth to those after natural

40 Observed frequencies were similar in men and women, with a slight male predominanc

41 on factors, and overexpression of IFN-beta mRNA and protein were similar in MSK1/2 and DUSP1 knockout macrophages.

42 Hemoglobin levels and international normalized ratio values were similar in patients receiving EBR/GZR and placebo; among

43 Changes in MRI features and peak breath hydrogen levels were similar in patients who did and did not reach the sympto

44 e found that M1 maps of the amputated limb in TMSR patients were similar in terms of extent, strength, and topography to

45 Both groups were similar in terms of substantial recanalization (Thrombol

46 In addition, the 2 groups were similar in terms of the proportion of patients presentin

47 Most clinical variables were similar in the 2 groups; however, there were significant

48 Estimated MLTs were similar in the ERSPC and PLCO intervention groups but we

49 The rates of renal adverse events were similar in the liraglutide group and the placebo group (

50 Rates of HIV viral suppression and adherence to ART were similar in the two groups.